跳至主要内容
临床试验/ITMCTR2000003950
ITMCTR2000003950招募中1 期

Study on the clinical effect and mechanism of Wuwei Baogan Pill in treating nonalcoholic fatty liver disease

Qingdao Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • According to the guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease (fatty liver and alcoholic liver disease Group of The Chinese Medical Association), the diagnostic criteria for non-alcoholic fatty liver disease and the TCM diagnosis are in line with the criteria for the syndrome of liver stagnation and spleen deficiency mainly combined with liver and kidney Yin deficiency and blood stasis blocking collateral.

排除标准

  • 1. Hepatitis virus marker positive;
  • 2. Patients with other serious cardiovascular, liver, kidney, lung, brain and blood system diseases;
  • 3. Allergic constitution or allergic to this drug;
  • 4. Have used other drugs to treat alcoholic fatty liver disease within one month;
  • 5. Pregnant or lactating women, psychopaths.

研究者

发起方
Qingdao Hospital of Traditional Chinese Medicine

相似试验

Study on the clinical effect and mechanism of Wuwei... | 临床试验